⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqCM

DNTH

Dianthus Therapeutics, Inc.

Healthcare · Biotechnology

76.78USD

-1.7500 (-2.23%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on DNTH.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 76.78
P/E—
Dvd Ind Yld0.0%
P/B3.58
P/S2,061.5
Curr EV/T12M EBITDA-15.7
Mkt Cap (USD)4.2B
Curr EV (USD)3.4B
2)

Per Share Data

EPS T12M-4.39
DPS—
Bk Val Per Sh21.39
Rev/Sh0.04
Cash/Sh15.86
Curr Shares Out54.7M
FCF/Sh-0.14
3)

Cash Flow Analysis

P/CF-27.0
Curr P/FCF-531.7
CF/NI0.8
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-7631.4%
Eff Interest Rate12.7%
4)

Growth Potential

Dil EPS 1Y Gr-64.7%
Cap 1Y Gr40.0%
BPS 1Y Gr20.8%
R&D To Sales8624.7%
Retention Rate100.0%
Rev 1Y Gr-67.3%
FCF 1Y Gr51.7%
Assets 1Y Gr42.0%
5)

Profitability

EBITDA-0.2B
EBIT-0.2B
Operating Margin-10699.6%
Pretax Margin—
Net Margin-9442.3%
ROA-25.0%
ROE-26.1%
ROC—
Asset Turnover0.00
6)

Structure

Current Ratio26.10
Quick Ratio25.79
Debt/Assets0.1%
Debt/Com Eq0.1%
Net Debt/EBITDA0.50
Tot Debt/Capital0.1%
Gross Margin100.0%
EBIT/Int Exp-1,336.5

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.